MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

156.33 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 156.33
Bid (Size) 155.66 (100)
Ask (Size) 157.50 (200)
Prev. Close 156.33
Today's Range 156.33 - 156.33
52wk Range 117.54 - 170.46
Shares Outstanding N/A
Dividend Yield 3.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
These companies' recent headwinds shouldn't lead to decreased payouts. 
Via The Motley Fool
Topics Intellectual Property
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts ↗
Via Chartmill

Performance

YTD
+12.8%
+12.8%
1 Month
+1.5%
+1.5%
3 Month
+7.6%
+7.6%
6 Month
-0.5%
-0.5%
1 Year
+31.9%
+31.9%

More News

Read More
News headline image
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗
Via The Motley Fool
Topics ETFs
News headline image
Novartis (NVS) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
NOVARTIS AG-SPONSORED ADR (NYSE:NVS): High-Quality Dividend Stock With Strong Profitability and Sustainable Payout ↗
Via Chartmill
News headline image
Novartis Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics ETFs Earnings
News headline image
Novartis Q2 2026 Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
Novartis Bounds For Buy Point. Why Shares Are On The Rise. ↗
Via Investor's Business Daily
News headline image
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline ↗
Via Benzinga
News headline image
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval ↗
Via Benzinga
News headline image
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
Via Newsfile
News headline image
Global Nitrogen-Containing Bisphosphonate Drugs Market Growing at 3.1% CAGR Through 2032 ↗
Via Talk Markets
News headline image
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
What Is the Vanguard International Dividend Appreciation ETF (VIGI), and Who Should Buy It? ↗
Via The Motley Fool
Topics ETFs Economy
News headline image
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up? ↗
Via The Motley Fool
Topics ETFs
News headline image
VYMI vs. VIGI: Which International Dividend ETF Is Better? ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
Via The Motley Fool
News headline image
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger ↗
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
Via Investor Brand Network
News headline image
Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push ↗
Via Benzinga
News headline image
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? ↗
Via The Motley Fool
Topics ETFs
News headline image
New Research Says: The Biggest Gains of AI Won't Go to AI Stocks. These 2 ETFs Could Be Better Buys. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand. ↗
Via The Motley Fool
Topics ETFs
News headline image
3 European Stocks to Carry Investors Through the Back Half of 2026 ↗
Via MarketBeat
Topics ETFs Stocks

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 156.33
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 08/07/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story